The world\'s first homozygous parthenogenetic stem cell lines that can provide therapeutic cells with the potential to be transplanted into hundreds o....
There’s no risk. Start your trial today to see profiles of International Stem Cell (OTCQB: ISCO) (aka ISCO) plus 5521 other startups.
Start Free 7 Day Trial Now
